Shoji Miki

Association of <i>HLA‐<scp>DRB1</scp>*09:01</i> with severe <scp>COVID</scp>‐19

Alitzel Anzurez, Izumi Naka, Shoji Miki et al. · HLA · 2021 · 51 citations · Full text

Generation of highly proliferative, rejuvenated cytotoxic T cell clones through pluripotency reprogramming for adoptive immunotherapy

Yohei Kawai, Ai Kawana‐Tachikawa, Shuichi Kitayama et al. · Molecular Therapy · 2021 · 34 citations · Full text

On-admission SARS-CoV-2 RNAemia as a single potent predictive marker of critical condition development and mortality in COVID-19

Shoji Miki, Hiroaki Sasaki, Hiroshi Horiuchi et al. · PLoS ONE · 2021 · 32 citations · Full text

Myeloid cell dynamics correlating with clinical outcomes of severe COVID-19 in Japan

Tomohiro Takano, Takayuki Matsumura, Yu Adachi et al. · International Immunology · 2021 · 27 citations · Full text

Breadth and Durability of SARS-CoV-2-Specific T Cell Responses following Long-Term Recovery from COVID-19

Thi Thu Thao Dang, Alitzel Anzurez, Kaori Nakayama‐Hosoya et al. · Microbiology Spectrum · 2023 · 10 citations · Full text